A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

Project: Research project

Project Details


Report on eligible participant enrollment at weekly intervals. Provide data to the Data Coordinating Center at regular intervals. Provide financial expenditure invoices/reports on a monthly basis and at other times when requested. Provide scientific progress reports as required by the prime grantee and the sponsor.
Effective start/end date10/1/209/30/22


  • Medical University of South Carolina (A00-3635-S021)
  • Lupus Foundation of America, Inc. (A00-3635-S021)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.